Data / Drug companies / Alkaloid
Alkaloid drugs: 3 drugs from 34 companies in the FDA NDC directory
Alkaloid is an FDA established pharmacologic class. The FDA National Drug Code Directory lists 50 products in this class from 34 companies, covering 3 drugs by generic name. The main marketing category is generic drugs (ANDA), and the newest product started marketing on August 27, 2026.
SpecStream is the live web data engine for teams and agents. It reads the National Drug Code Directory that FDA publishes, and this page is that reading. Ask for the companies that make a drug, a class or a dosage form, with their headquarters, website and size added from the web, and new listings and discontinued products arrive in your sheet, CRM, Slack or agent as FDA posts them.
- 34Companies
- 50Products
- 3Drugs by generic name
Drugs in the Alkaloid class
Ranked by number of companies that list the drug.
| Drug | Products here | Companies listing it |
|---|---|---|
| Colchicine | 45 | 34 |
| Probenecid and colchicine | 4 | 4 |
| Colchicine tablets 0.5 mg | 1 | 1 |
Companies with the most products in this class
| Company | Products | Main dosage forms | Main marketing category | Newest product started |
|---|---|---|---|---|
| Bryant Ranch Prepack | 4 | tablet, film coated; capsule | Generic drugs (ANDA) | April 29, 2024 |
| Bryant Ranch Prepack | 4 | tablet, film coated; tablet | Authorized generics (NDA) | February 10, 2019 |
| Direct_Rx | 3 | tablet, film coated; tablet | Generic drugs (ANDA) | August 27, 2026 |
| Remedyrepack Inc. | 3 | tablet; tablet, film coated | Generic drugs (ANDA) | April 28, 2026 |
| A-S Medication Solutions | 2 | tablet; capsule | Generic drugs (ANDA) | February 10, 2019 |
| American Health Packaging | 2 | capsule; tablet, film coated | New drug applications (NDA) | August 1, 2023 |
| Aurobindo Pharma Limited | 2 | tablet; capsule | Generic drugs (ANDA) | April 29, 2024 |
| Coupler LLC | 2 | capsule | New drug applications (NDA) | December 30, 2025 |
| Granules Pharmaceuticals Inc. | 2 | tablet, film coated; capsule | Generic drugs (ANDA) | April 29, 2024 |
| Major Pharmaceuticals | 2 | tablet, film coated; capsule | Generic drugs (ANDA) | May 13, 2020 |
| Actavis Pharma, Inc. | 1 | tablet | Generic drugs (ANDA) | October 1, 1982 |
| Agepha Pharma USA, LLC | 1 | tablet | New drug applications (NDA) | June 16, 2023 |
| Amneal Pharmaceuticals LLC | 1 | tablet | Generic drugs (ANDA) | September 30, 2016 |
| Ascend Laboratories, LLC | 1 | tablet | Generic drugs (ANDA) | February 10, 2019 |
| AvPAK | 1 | tablet | Generic drugs (ANDA) | September 15, 2021 |
| Bryant Ranch Prepack | 1 | tablet | Generic drugs (ANDA) | February 10, 2019 |
| Camber Pharmaceuticals, Inc. | 1 | capsule | Generic drugs (ANDA) | April 29, 2024 |
| Chartwell RX, LLC | 1 | tablet, film coated | Generic drugs (ANDA) | March 26, 2023 |
| Dr. Reddy's Laboratories Inc. | 1 | tablet | Generic drugs (ANDA) | June 11, 2020 |
| Golden State Medical Supply, Inc. | 1 | tablet, film coated | Generic drugs (ANDA) | February 5, 2020 |
| Hikma Pharmaceuticals USA Inc. | 1 | capsule | Authorized generics (NDA) | October 1, 2014 |
| Ingenus Pharmaceuticals, LLC | 1 | tablet | Generic drugs (ANDA) | May 16, 2019 |
| Macleods Pharmaceuticals Limited | 1 | tablet | Generic drugs (ANDA) | April 24, 2017 |
| Micro Labs Limited | 1 | capsule | Generic drugs (ANDA) | February 18, 2026 |
| Mylan Pharmaceuticals Inc. | 1 | tablet, film coated | Generic drugs (ANDA) | November 25, 2019 |
| NuCare Pharmaceuticals,Inc. | 1 | tablet | Generic drugs (ANDA) | February 10, 2019 |
| PD-Rx Pharmaceuticals, Inc. | 1 | tablet, film coated | Generic drugs (ANDA) | August 13, 2021 |
| Par Health USA, LLC | 1 | tablet, film coated | Generic drugs (ANDA) | September 27, 2022 |
| Par Health USA, LLC | 1 | capsule | Generic drugs (ANDA) | November 1, 2023 |
| Proficient Rx LP | 1 | tablet, film coated | New drug applications (NDA) | September 1, 2009 |
| Proficient Rx LP | 1 | tablet | Generic drugs (ANDA) | June 11, 2020 |
| Rising Pharma Holdings, Inc. | 1 | tablet | Generic drugs (ANDA) | October 24, 2023 |
| Scilex Pharmaceuticals Inc. | 1 | solution | New drug applications (NDA) | January 31, 2024 |
| St. Mary's Medical Park Pharmacy | 1 | tablet | Generic drugs (ANDA) | April 23, 2026 |
Dosage forms
| Dosage form | Products | Share |
|---|---|---|
| Tablet | 21 | 42% |
| Tablet, film coated | 16 | 32% |
| Capsule | 12 | 24% |
| Solution | 1 | 2% |
Updated November 6, 2026. Read from US Food and Drug Administration, National Drug Code Directory (openFDA). CC0 1.0 public domain dedication (openFDA). Counts are products in the FDA National Drug Code Directory on November 6, 2026: 138,262 products in commercial distribution, meaning without a marketing end date in the past. A company is a labeler code; one company can hold several codes, and the directory carries no address. Inclusion in the directory is not FDA approval, and the marketing category says under which kind of application or rule a product is sold. This page uses openFDA data and is not endorsed or certified by FDA. Free to reuse with credit to SpecStream under CC BY 4.0. Spot a wrong value? Write to [email protected] with the link to this page.